Cargando…
Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA
BACKGROUND: Currently, resistance to tyrosine kinase inhibitors, such as gefitinib, has become a major obstacle in improving the clinical outcome of patients with metastatic and advanced-stage esophageal squamous cell carcinoma (ESCC). While cell behavior can be modulated by long non-coding RNAs (ln...
Autores principales: | Kang, Min, Ren, Meiping, Li, Yan, Fu, Yuqiong, Deng, Minmin, Li, Changping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063009/ https://www.ncbi.nlm.nih.gov/pubmed/30049286 http://dx.doi.org/10.1186/s13046-018-0845-9 |
Ejemplares similares
-
Retraction Note: Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA
por: Kang, Min, et al.
Publicado: (2023) -
Comprehensive analysis of lncRNA-associated competing endogenous RNA network in tongue squamous cell carcinoma
por: Zhang, Shusen, et al.
Publicado: (2019) -
Investigation of miRNA- and lncRNA-mediated competing endogenous RNA network in cholangiocarcinoma
por: He, Yanxin, et al.
Publicado: (2019) -
Analysis of the lncRNA-Associated Competing Endogenous RNA (ceRNA) Network for Tendinopathy
por: Huang, Bing-Zhe, et al.
Publicado: (2022) -
Comprehensive analysis of the lncRNA-associated competing endogenous RNA network in breast cancer
por: Wang, Jing-Jing, et al.
Publicado: (2019)